CASI Pharmaceuticals Q1 EPS $(0.71) Misses $(0.05) Estimate, Sales $3.41M Miss $12.00M Estimate
CASI Pharmaceuticals Q1 EPS $(0.71) Misses $(0.05) Estimate, Sales $3.41M Miss $12.00M Estimate
CASI Pharmicals第一季度每股收益美元（0.71美元）未达到预期（0.05美元），销售额为341万美元，低于1,200万美元的预期
CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.05) by 1320 percent. This is a 57.78 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $3.41 million which missed the analyst consensus estimate of $12.00 million by 71.59 percent. This is a 59.16 percent decrease over sales of $8.35 million the same period last year.
CASI制药公司（纳斯达克股票代码：CASI）公布的季度亏损为每股0.71美元（0.71美元），比分析师普遍预期的0.05美元（0.05美元）低1320个百分点。这比去年同期每股亏损0.45美元（0.45美元）下降了57.78％。该公司公布的季度销售额为341万美元，比分析师普遍预期的1,200万美元低71.59％。这比去年同期的835万美元销售额下降了59.16％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。